advanced genomics limited
advanced genomics limited Company Information
Company Number
13082367
Next Accounts
Sep 2025
Shareholders
lee silcock
christopher david sale
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
unit 5 quinton business park, 11 ridgeway, birmingham, B32 1AF
Website
nonacus.comadvanced genomics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED GENOMICS LIMITED at £3.2m based on a Turnover of £2.5m and 1.28x industry multiple (adjusted for size and gross margin).
advanced genomics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED GENOMICS LIMITED at £0 based on an EBITDA of £-8.3m and a 5.05x industry multiple (adjusted for size and gross margin).
advanced genomics limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED GENOMICS LIMITED at £32.7m based on Net Assets of £18.3m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanced Genomics Limited Overview
Advanced Genomics Limited is a live company located in birmingham, B32 1AF with a Companies House number of 13082367. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in December 2020, it's largest shareholder is lee silcock with a 31.3% stake. Advanced Genomics Limited is a young, small sized company, Pomanda has estimated its turnover at £2.5m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Advanced Genomics Limited Health Check
Pomanda's financial health check has awarded Advanced Genomics Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
4 Weak
Size
annual sales of £2.5m, make it smaller than the average company (£4.5m)
£2.5m - Advanced Genomics Limited
£4.5m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Advanced Genomics Limited
- - Industry AVG
Production
with a gross margin of 45.7%, this company has a comparable cost of product (54%)
45.7% - Advanced Genomics Limited
54% - Industry AVG
Profitability
an operating margin of -363.6% make it less profitable than the average company (-4.8%)
-363.6% - Advanced Genomics Limited
-4.8% - Industry AVG
Employees
with 77 employees, this is above the industry average (54)
77 - Advanced Genomics Limited
54 - Industry AVG
Pay Structure
on an average salary of £76.7k, the company has an equivalent pay structure (£83.1k)
£76.7k - Advanced Genomics Limited
£83.1k - Industry AVG
Efficiency
resulting in sales per employee of £32k, this is less efficient (£131.2k)
£32k - Advanced Genomics Limited
£131.2k - Industry AVG
Debtor Days
it gets paid by customers after 62 days, this is near the average (56 days)
62 days - Advanced Genomics Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 158 days, this is slower than average (61 days)
158 days - Advanced Genomics Limited
61 days - Industry AVG
Stock Days
it holds stock equivalent to 171 days, this is more than average (48 days)
171 days - Advanced Genomics Limited
48 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 649 weeks, this is more cash available to meet short term requirements (30 weeks)
649 weeks - Advanced Genomics Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5.4%, this is a lower level of debt than the average (53.1%)
5.4% - Advanced Genomics Limited
53.1% - Industry AVG
ADVANCED GENOMICS LIMITED financials
Advanced Genomics Limited's latest turnover from December 2023 is £2.5 million and the company has net assets of £18.3 million. According to their latest financial statements, Advanced Genomics Limited has 77 employees and maintains cash reserves of £13 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Turnover | 2,463,627 | 9,821,630 | |
| Other Income Or Grants | |||
| Cost Of Sales | 1,337,138 | 3,021,579 | |
| Gross Profit | 1,126,489 | 6,800,051 | |
| Admin Expenses | 10,085,270 | 5,823,869 | |
| Operating Profit | -8,958,781 | 976,182 | |
| Interest Payable | 273 | 243 | |
| Interest Receivable | 405,463 | ||
| Pre-Tax Profit | -8,553,591 | 975,939 | |
| Tax | 442,053 | 203,365 | |
| Profit After Tax | -8,111,538 | 1,179,304 | |
| Dividends Paid | |||
| Retained Profit | -8,111,538 | 1,179,304 | |
| Employee Costs | 5,905,779 | 3,811,387 | |
| Number Of Employees | 77 | 65 | |
| EBITDA* | -8,319,714 | 1,376,928 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Tangible Assets | 4,068,086 | 4,273,594 | |
| Intangible Assets | |||
| Investments & Other | 744,996 | 499,996 | |
| Debtors (Due After 1 year) | |||
| Total Fixed Assets | 4,813,082 | 4,773,590 | |
| Stock & work in progress | 627,592 | 363,483 | |
| Trade Debtors | 422,123 | 251,164 | |
| Group Debtors | |||
| Misc Debtors | 468,533 | 889,609 | 1 |
| Cash | 12,971,492 | 22,252,729 | |
| misc current assets | |||
| total current assets | 14,489,740 | 23,756,985 | 1 |
| total assets | 19,302,822 | 28,530,575 | 1 |
| Bank overdraft | |||
| Bank loan | |||
| Trade Creditors | 581,378 | 1,142,275 | |
| Group/Directors Accounts | |||
| other short term finances | |||
| hp & lease commitments | |||
| other current liabilities | 456,409 | 320,647 | |
| total current liabilities | 1,037,787 | 1,462,922 | |
| loans | |||
| hp & lease commitments | |||
| Accruals and Deferred Income | |||
| other liabilities | |||
| provisions | 702,260 | ||
| total long term liabilities | 702,260 | ||
| total liabilities | 1,037,787 | 2,165,182 | |
| net assets | 18,265,035 | 26,365,393 | 1 |
| total shareholders funds | 18,265,035 | 26,365,393 | 1 |
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | -8,958,781 | 976,182 | |
| Depreciation | 639,067 | 400,746 | |
| Amortisation | |||
| Tax | 442,053 | 203,365 | |
| Stock | 264,109 | 363,483 | |
| Debtors | -250,117 | 1,140,772 | 1 |
| Creditors | -560,897 | 1,142,275 | |
| Accruals and Deferred Income | 135,762 | 320,647 | |
| Deferred Taxes & Provisions | -702,260 | 702,260 | |
| Cash flow from operations | -9,019,048 | 2,241,220 | |
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | 245,000 | 499,996 | |
| cash flow from investments | -245,000 | -499,996 | |
| Financing Activities | |||
| Bank loans | |||
| Group/Directors Accounts | |||
| Other Short Term Loans | |||
| Long term loans | |||
| Hire Purchase and Lease Commitments | |||
| other long term liabilities | |||
| share issue | |||
| interest | 405,190 | -243 | |
| cash flow from financing | 416,370 | 25,185,845 | |
| cash and cash equivalents | |||
| cash | -9,281,237 | 22,252,729 | |
| overdraft | |||
| change in cash | -9,281,237 | 22,252,729 |
advanced genomics limited Credit Report and Business Information
Advanced Genomics Limited Competitor Analysis
Perform a competitor analysis for advanced genomics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in B32 area or any other competitors across 12 key performance metrics.
advanced genomics limited Ownership
ADVANCED GENOMICS LIMITED group structure
Advanced Genomics Limited has 1 subsidiary company.
advanced genomics limited directors
Advanced Genomics Limited currently has 3 directors. The longest serving directors include Mr Lee Silcock (Dec 2020) and Mr Graham Snudden (Dec 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Lee Silcock | England | 42 years | Dec 2020 | - | Director |
| Mr Graham Snudden | England | 61 years | Dec 2020 | - | Director |
| Mr Christopher Sale | England | 48 years | Dec 2020 | - | Director |
P&L
December 2023turnover
2.5m
-75%
operating profit
-9m
-1018%
gross margin
45.8%
-33.96%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
18.3m
-0.31%
total assets
19.3m
-0.32%
cash
13m
-0.42%
net assets
Total assets minus all liabilities
Similar Companies
advanced genomics limited company details
company number
13082367
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
December 2020
age
5
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
COGNITOR ACCOUNTANCY LIMITED
address
unit 5 quinton business park, 11 ridgeway, birmingham, B32 1AF
Bank
-
Legal Advisor
-
advanced genomics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to advanced genomics limited.
advanced genomics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCED GENOMICS LIMITED. This can take several minutes, an email will notify you when this has completed.
advanced genomics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
